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The aim of the present investigation was to elucidate the cellular mechanisms whereby Tanshinone IIA (Tan IIA) leads to
cell cycle arrest and apoptosis in vitro in keratinocytes, the target cells in psoriasis. Tan IIA inhibited proliferation of mouse
keratinocytes in a dose- and time-dependent manner and induced apoptosis, resulting in S phase arrest accompanied by down-
regulation of pCdk2 and cyclin A protein expression. Furthermore, Tan IIA-induced apoptosis and mitochondrial membrane
potential changes were also further demonstrated by DNA fragmentation, single-cell gel electrophoresis assay (SCGE), and ﬂow
cytometry methods. Apoptosis was partially blocked by the caspase-3 inhibitor Ac-DEVD-CHO. Mitochondrial regulation of
apoptosis further downstream was investigated, showing changes in the mitochondrial membrane potential, cytochrome c release
into the cytoplasm, and enhanced activation of cleaved caspase-3 and Poly ADP-ribose polymerase (PARP). There was also no
translocation of apoptosis-inducing factor (AIF) from mitochondria to the nucleus in apoptotic keratinocytes, indicating Tan IIA-
induced apoptosis occurs mainly through the caspase pathway. Our ﬁndings provide the molecular mechanisms by which Tan IIA
can be used to treat psoriasis and support the traditional use of Salvia miltiorrhiza Bungee (Labiatae) for psoriasis and related skin
diseases.
1.Introduction
Psoriasis is a chronic inﬂammatory skin disease aﬀecting
0.6% to 4.8% of people worldwide [1]. Excessive prolifer-
ation of keratinocytes, abnormalities in the diﬀerentiation
process,andcontinuoussheddingofthethickenedepidermis
are characteristics of psoriasis (Figures 1(a) and 1(b)) [2].
The underlying cause of psoriasis, however, is not well
understood.
In China, patients with psoriasis often turn to alterna-
tive and complementary treatments, which are considered
eﬀective and safe [3]. The use of herbal medicines to prevent
the development as well as recurrence of psoriasis and other
inﬂammatory diseases has become widely accepted. Dan-
shen, a traditional Chinese crude drug, was one of the most
widely used in traditional Chinese medicine. Tanshinone IIA
(Tan IIA) is one of the main natural active ingredients puri-
ﬁed from Salvia miltiorrhiza radix, which has been widely
usedinclinicalpracticeforthepreventionofpsoriasis,atopic
dermatitis, and other inﬂammation-related disorders.
Other investigators have explored the involvement of
Tan IIA in causing apoptosis [4–7]. Despite the tremendous
progressthathasbeenmadeinthetherapeuticuseofTanIIA,
the molecular mechanism(s) involved in the treatment of
psoriasis remain(s) unresolved. Numerous studies have doc-
umented the consequences of Tan IIA treatment, including
apoptotic eﬀects against leukemia [8, 9], hepatocarcinoma
[10], breast cancer [11], colon cancer [11], and gliomas [12].
Although,mostofthesestudieshavefocusedontreatmentof
tumors, the eﬀects and mechanism of action in keratinocytes2 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Clinical and pathological presentation of psoriasis and chemical structure of tanshinone IIA. (a) A 55-year-old woman with
psoriasissuﬀeredfromerythematousplaqueswithlimitedsilverysaleonherlegslastingaslongas5years.(b)Epidermalregularpsoriasiform
hyperplasia in the epidermis and parakeratosis with Munro’s microabscesses. (c) Chemical structure of tanshinone IIA.
arestillpoorlyunderstood.Therefore,basedonclinicalexpe-
rience as well as cytotoxic activity against multiple human
cancer cells, we hypothesized that induction of apoptosis is
the underlying mechanism for the treatment of psoriasis.
We investigated the eﬀects of various concentrations of Tan
IIA(5–10μg/mL)onmousekeratinocytesandhumanHaCat
cells in vitro to conﬁrm this hypothesis. Protein and gene
expression of apoptotic signaling pathway-related proteins
such as caspase-3, cytochrome c, and PARP were determined
to provide evidence for the mechanisms of action of Tan IIA
in the treatment of psoriasis.
2.MaterialsandMethods
2.1. Chemicals and Reagents. Tan IIA (Figure 1(c); 99.2%
purity) was purchased from the National Institute for
the Control of Pharmaceutical and Biological Products
(Shanghai,China)andcompletelydissolvedinDMSO(shake
overnight in 37◦C) at a stock concentration of 4mg/mL.
Propidium iodide (PI) and the enhanced apoptotic DNA
ladder detection kit were purchased from BioVision Inc.
(Mountain View, CA, USA). Apo-BrdU apoptosis detection
kit and mitochondrial membrane potential detection kit
were purchased from BD Biosciences (San Diego, CA, USA).
An OxiSelect Comet Assay Kit was purchased from Cell
Biolabs Inc. (San Diego, CA, USA). Antibodies for detection
of the apoptosis and cell cycle-related proteins caspase-
3 (1:200), PARP (1:1000), PCNA (1:500), AIF (1:500),
and pCDK2 (1:200) were purchased from Cell Signaling
Technology (Beverly, MA, USA). Cyclin A and cytochrome c
were purchased from BD Biosciences (San Diego, CA, USA)
and α-tubulin was purchased from Sigma Chemical Co. (St.
Louis, MO, USA). ELISA testing kits for caspase-3 and -8
were purchased from BioVision Company (Mountain View,
CA, USA).
2.2. Cell Culture. Primary mouse keratinocytes were pre-
pared from newborn mice as previously described [13],
and cultured in Cnt-07 medium and supplements (Cell-
ntec, Berne, Switzerland). Dr. Juan Wang at the Shanghai
Institute of Pharmaceutical Industry kindly provided the
HaCat human keratinocyte cell line. HaCat cells were
cultured in Dulbecco’s modiﬁed Eagle’s medium (DMEM;
Invitrogen, Carlsbad, CA, USA.) supplemented with 10%
heat-inactivated fetal bovine serum (FBS) and 100U/mL
penicillin.Thecellswereincubatedat37◦Cinanatmospher e
of 5% CO2.
2.3. Cell Growth Inhibitory Rate (MTS/PMS) Assay. Cell
growth inhibitory rate was assayed using the MTS/PMS
method. Brieﬂy, cells (1 × 103/well) were plated in 96-well
culture plates (Nunclon, Nunc, Roskide, Denmark). After
incubation overnight, diﬀerent concentrations of Tan IIA
( 2 . 5 ,5 ,o r1 0 μg/mL) were added to various wells. Each
of the concentrations above was regarded as one treated
group while the control group only contained DMSO. Each
group contained 6 replicate wells. After culture plates were
incubated for 0, 24, 48, or 72h, 100μLo fM T S / P M S
working solution was added to each well and then the
keratinocytes were incubated continuously for another 4h.
The absorbance (A value) of each well was measured
using a spectrophotometer (Beckman Coulter; Miami, FL,
USA) at 490nm. The eﬀect of Tan IIA on the cell growth
inhibitory rate in keratinocytes was calculated according to
the following formula: % inhibitory rate = A490 value of
treated group/A490 value of control group ×100%. The 50%Evidence-Based Complementary and Alternative Medicine 3
inhibitory concentration (IC50) was determined from dose-
response data from at least 3 independent experiments.
2.4. Clonogenic Survival Determination. Cells were assayed
fortheircolony-formingabilitybyreplatingthematspeciﬁed
numbers (300–400cells/well) in 6-well plates treated with
2.5, 5.0, or 10.0μg/mL of Tan IIA. After 7 days of incubation,
cellswerestainedwith0.5%crystalvioletinabsoluteethanol,
and colonies with >50 cells were counted under a dissecting
microscope.
2.5. Cell Cycle Analysis. Cells were plated at a density of
1.5×106 per6cmdiameterdishandallowedtogrowfor24h,
afterwhichthemediumwaschangedtoserum-freemedium.
After 16–18h of starvation, cells are synchronized in the G0
phase of the cell cycle. Diﬀerent experimental reagents were
then added to the serum-free medium. Cells (1 × 106)w e r e
harvested by trypsinization after the indicated treatment,
washed twice in cold PBS, and then ﬁxed in 70% alcohol
for 30min on ice. After washing in cold PBS three times,
cells were resuspended in 1mL of Krishan staining solution
[14]overnightat4◦C.A96-micronporesizenylonmeshwas
used to ﬁlter cells the next day, and a total of 10,000 stained
nuclei were analyzed with a ﬂow cytometer (BD Biosciences;
San Jose, CA, USA). DNA histograms were prepared using
the ModFit analysis program (BD Biosciences; San Jose, CA,
USA), which ﬁts the fractions of cells in the G0-G1,S ,a n d
G2-M phases of the cell cycle. Each condition was repeated in
triplicate.
2.6. Flow Cytometry Analysis for Cell Apoptosis. Mouse
keratinocytes in log-phase growth were exposed to diﬀer-
ent concentrations of Tan IIA (from 2.5 to 10.0μg/mL),
harvested, and processed for ﬂow cytometry (Beckman
Coulter Gallios) using the TUNEL-based Apo-BrdU Kit (BD
Biosciences), according to the manufacturer’s instructions.
Floating and attached cells were incubated with DNA
labeling solution containing BrdU, harvested at 24, 48, and
72h of Tan IIA exposure, and subsequently ﬁxed with 4%
paraformaldehyde. After washing, samples were incubated
with ﬂuorescein-labeled anti-BrdU, pelleted, and washed
with wash buﬀer. Cells were incubated with RNase/PI
solution provided by the Apo-BrdU Kit and kept in the dark
at 4◦C overnight. Cells were analyzed by ﬂow cytometry
using the doublet discrimination module and data were
acquiredusingCellQuest(BDBiosciences)software.Thecell
cycle was modeled and data were expressed as a percentage
of apoptotic cells in the total cell preparation. All data
were collected and analyzed by Lysis II software (Becton
Dickinson). The experiments were repeated 3 times and the
results are presented as mean ± SD.
2.7. Immunoﬂuorescence Staining. Cells were cultured on 8-
well chamber slides (Fisher Brand) and treated with diﬀerent
concentrations of Tan IIA for 24h. Cells were then ﬁxed
with 4% paraformaldehyde, permeabilized with 0.3% Triton
X-100, digested in pepsin solution (Lab Vision, Thermo
Scientiﬁc Corporation; Waltham, MA, USA), blocked for 1h
with 10% normal goat serum plus 0.1% NP-40, and incu-
bated with target primary antibodies overnight. Alexa Fluor
488- or 594-conjugated secondary antibodies (Invitrogen)
wereusedforimmunoﬂuorescencestaining,andimageswere
taken using confocal microscopy with a Leica SP2 confocal
microscope (Leica Microsystems Inc.; Deerﬁeld, IL, USA).
2.8. DNA Fragmentation Assay. Apoptosis was determined
with the enhanced apoptotic DNA ladder detection kit
according to the manufacturer’s instructions (BioVision
Company). Brieﬂy, keratinocytes (10 × 105) were collected,
washed with PBS twice, and cells were pelleted by centrifuga-
tion for 5min at 500×g. Enzyme B (protein kinase) solution
(5μL) was added to each sample and they were incubated at
50◦C overnight. Cells were then lysed with 35μLo fT El y s i s
buﬀer (50mM Tris-HCl [pH 7.4], 20mM EDTA containing
1% sodium dodecyl sulfate [SDS]), and incubated at 37◦C
for 10min. Ammonium acetate solution (5μL) was added
to each sample, mixed well, 50μL of isopropanol was added,
and samples kept at −20◦C for 10min. Samples were then
centrifuged for 10min to precipitate DNA, the pellet was
washed with 0.5mL of 70% ethanol, and air dried for 10min
at room temperature. The DNA pellet was dissolved in
20μL of DNA suspension buﬀer, electrophoresed on a 1.8%
agarose gel, visualized under UV light, and photographed.
2.9. Single-Cell Gel Electrophoresis Assay. The single-cell
electrophoresis assay was performed using the Comet Assay
Kit (Cell Biolabs Inc., San Diego, CA, USA). Brieﬂy, ker-
atinocytes were treated with 10μg/mL of Tan IIA for 24h.
The cells were then washed with cold PBS, scraped, collected
into 1.5mL tubes, and centrifuged. The cell pellet was then
combined with Comet Agarose at 1:10 ratio (v/v), mixed,
and 75μL/well was immediately pipetted onto the Comet
assay slide. The slides were dried completely at 4◦C in the
dark for 15min followed by incubation in prechilled Lysis
solution at 4◦C in the dark for another 15min. After washing
withTBEbuﬀer(50mMTris,50mMboricacid,and0.2mM
EDTA), the samples were subjected to electrophoresis at
31V for 30min in TBE and stained with vista green DNA
dye. The signal was detected with a Nikon ﬂuorescent
microscope (Nikon; Tokyo, Japan). Tail DNA% of 100 cells
in each slide was measured using NIH Image J software
(http://rsb.info.nih.gov/ij/; NIH; Bethesda, MD, USA).
2.10. Western Blot Analysis. Western blot analysis was
completed as described by Sambrook et al. [15]. Ker-
atinocytes were cultured as before. After culture, the cells
were harvested and lysed with lysis buﬀer (20mM Tris-
HCl (pH 7.5), 150mM NaCl, 1mM Na2EDTA, 1mM
EGTA, 1% Triton, 1%NP-40, 2.5mM sodium pyrophos-
phate, 1mM β-glycerophosphate, 1mM leupeptin, and
1mM phenylmethylsulfonyl ﬂuoride (PMSF)), for 30min at
4◦C. The insoluble material was removed by centrifugation
at 10.000rpm for 10min at 4◦C. The concentration of
protein in each cell lysate was measured with bovine serum
albumin (BSA) as a protein standard (Sigma). An identical
amountofprotein(50μg)fromeachsamplewasloadedonto4 Evidence-Based Complementary and Alternative Medicine
a 10% SDS-PAGE gel and electrophoresed at 100V. Proteins
were then transferred to nitrocellulose membranes (0.45μm;
Millipore; Billerica, MA, USA) and blocked with 5% nonfat
milk in TBS (25mM Tris-HCl, 150mM sodium chloride, pH
7.2) for 1h at room temperature. The blots were incubated
with primary antibodies at a dilution of 1:1000 in blocking
buﬀer overnight at 4◦C. The membranes were washed three
times and then incubated with horseradish peroxidase-
(HRP-) conjugated goat anti-rabbit/(mouse) IgG (1:5000 in
Odyssey blocking buﬀer; Li-Cor Biosciences; Lincoln, NE,
USA) for 1h at room temperature. Gray-scale images were
obtained and quantiﬁed with Odyssey v.1.2 software (LI-Cor
Biosciences; Lincoln, NE, USA).
2.11. Mitochondrial Membrane Potential Assay. Cells were
seeded in 12-well plates for 24h and stained with the JC-1
reagent from BD Biosciences (San Jose, CA, USA) accord-
ing to the manufacturer’s instructions. After incubation
for 15min, JC-1 aggregates in the mitochondria (only in
live cells) were detected as a red color by a ﬂuorescence
microscope using excitation/emission = 540/570nm. JC-
1 monomers in the cytoplasm (in both live and apoptotic
cells) were detected as a green color at excitation/emission =
490/520nm.
2.12. Caspase-3 Activity Assay. Caspase-3 activity was deter-
mined using the ﬂuorescent substrate DEVD-afc according
to the manufacturer’s instructions (BioVision, Inc., Moun-
tain View, CA, USA). Brieﬂy, at 6, 12, and 24h both Tan
IIA-treated and untreated cells were isolated by scraping the
dish with a rubber policeman and centrifuged at 400×g
for 10min. The supernatant was removed, the pellet was
suspended in 100μLo fl y s i sb u ﬀer (BioVision, Inc.), and
incubated at 4◦C for 10min followed by centrifugation at
12.000×g for 10min. Aliquots (50μL) of the supernatant
were removed and placed in a 96-well microplate containing
reaction buﬀer (BioVision, Inc.). Substrate was added and
the microplate was incubated at 37◦Cf o r2h .A c t i v i t yw a s
monitored by the linear cleavage and release of the afc-side
chain and compared with a linear standard curve generated
on the same microplate.
2.13. Statistical Analyses. All experiments were performed
at least three times. Values are expressed as means ± SEM.
Statistical analyses were carried out using one-way analysis
of variance (ANOVA) followed by the least signiﬁcant
diﬀerence (LSD) post hoc t-test. Statistical signiﬁcance was
accepted at the level of P<0.05.
3. Results
3.1. Inhibitory Eﬀe c to fT a nI I Ao nt h eG r o w t ho fK e r -
atinocytes. We investigated the concentration- and time-
dependent patterns of the antiproliferation eﬀect of Tan
IIA, using the MTS/PMS assay (Figure 2). After exposure to
Tan IIA, keratinocytes showed consistent growth retardation
compared with the control group. The data unambiguously
conﬁrmed that Tan IIA exerted potent growth inhibitory
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Figure 2: Eﬀects of tanshinone IIA on cell viability of mouse
keratinocytes. Dose- and time-dependent growth inhibition was
observed at concentrations ranging from 1.0 to 10.0μg/mL. Results
are expressed as a percentage of the control (100%) and represent
the mean ± SD of independent experiments performed at least in
triplicate.
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Figure 3: Inhibition of colony formation of mouse keratinocytes
by tanshinone IIA. Colony formation inhibition occurred in a
dose-dependent manner. Results are means ± SD of independent
experiments performed in triplicate. The asterisk indicates a
signiﬁcant diﬀerence between control and tanshinone IIA-treated
cells (∗P<0.05, ∗∗P<0.01).
eﬀects on keratinocytes in a concentration- and time-
dependent manner. The IC50 values for the eﬀects of Tan IIA
on the growth of keratinocytes when incubated for 24, 48,
and 72h were 4.33±1.35, 1.89±0.65, and 1.14±0.87μg/mL,
respectively.
3.2. Analysis of Clonogenic Survival. To further measure the
inhibitory eﬀect of Tan IIA on keratinocytes, colony number
growth curves were generated for each clone over a 1-week
period (Figure 3). By day 3, the control group produced
33.5 ± 7.1 colonies while Tan IIA-treated groups exhibited
only 12.0±1.0( P<0.05) and 8.25±1.01 (P<0.05) colonies
with 2.5 and 5.0μg/mL, respectively. By day 7, the DMSOEvidence-Based Complementary and Alternative Medicine 5
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Figure 4: Morphology of keratinocytes exposed to tanshinone IIA. Detection of tanshinone IIA-induced apoptosis in keratinocytes under
light microscopy. With increasing concentrations of tanshinone IIA, diﬀerent features of chromatin clumps (several diﬀerent forms of
chromatin aggregation, arrows) were clearly observed. Detection of apoptotic cells gradually increased in a dose-dependent manner. Marked
morphological changes of cellular apoptosis, including condensation of chromatin and nuclear fragmentation, were clearly observed. Each
experiment was performed in triplicate. The scale bar in the ﬁrst panel represents 50μm for all sections.
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Figure 5: Tanshinone IIA induces apoptosis in mouse keratinocytes. Detection of tanshinone IIA-induced apoptosis and necrosis was
measured by (a) ﬂow cytometry after Hoechst 33324/PI staining. (b) Graph represents means ± SD of percent of apoptotic cells of ﬂow
cytometry results. (c) Detection of tanshinone IIA-induced apoptosis with Apo-BrdU staining followed by ﬂow cytometry. Asterisk marks
indicate a signiﬁcant diﬀerence between control and tanshinone IIA-treated cells (∗P<0.05, ∗∗P<0.01).
controlgroupofkeratinocytesproducedmuchhighercolony
numbers of 164 ± 22 while Tan IIA groups only produced
95.0 ± 11.1( P<0.05), 34.5 ± 4.9( P<0.05), and 11.8 ± 3.8
(P<0.05) colonies with 2.5, 5.0, and 10.0μg/mL Tan IIA,
respectively. These results show that with increasing concen-
trations of Tan IIA, cell colony formation was progressively
inhibited.ThehighestconcentrationofTanIIA(10.0μg/mL)
exhibited almost complete inhibition of colony formation.
3.3. Tan IIA-Induced Alterations of Cellular Morphology.
A f t e re x p o s u r et od i ﬀerent concentrations of Tan IIA for
24, 48, or 72h, marked morphological changes indicative6 Evidence-Based Complementary and Alternative Medicine
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Figure 6: DNA damage analysis by fragmentation assay and OxiSelect Comet assay. (a) DNA ladder was clearly observed at 10μg/mL
concentration of tanshinone IIA. (b) OxiSelect Comet Assay Kit results of tanshinone IIA treatment. Keratinocytes were untreated (left)
or treated (right) with tanshinone IIA (10μg/mL, 24h) and analysis of apoptosis was performed by the Comet assay. (c) Graph represents
means ± SD of percent of tail DNA% from 100 cells.
of apoptosis were observed (Figure 4). These included
condensation and fragmentation of the nuclear chromatin,
shrinkage of the cytoplasm, and loss of membrane asymme-
try (arrows). Such apoptotic features were rarely observed
in the control group. These morphological changes indicate
that Tan IIA has the capability of inducing cellular apoptosis
in cultured mouse keratinocytes. We also obtained the same
results in human HaCat keratinocytes (data not shown).
3.4. Analysis of Apoptosis Induced by Tan IIA. To determine
the contribution of cell death to Tan IIA-induced reduction
in cell growth, we employed two diﬀerent methods to detect
apoptotic cells: Hoechst staining and Apo-BrdU labeling
followed by ﬂow cytometry detection. Hoechst staining
was observed under ﬂuorescence microscopy, and more
f r e q u e n t l ys h o w e dc o n d e n s e da n df r a g m e n t e dn u c l e ii nT a n
IIA-treated groups than in the control group. These ﬁndings
were further conﬁrmed by ﬂow cytometry detection of both
Hoechst and Apo-BrdU labeling methods. As shown in
Figure 5(a), with increasing exposure concentrations of Tan
IIA, the percentage of apoptotic cells was increased (23.2%,
40.2%, and 58.3%, for 2.5, 5.0 and 10.0μg/mL Tan IIA,
resp.,) as compared to that in the control group, which
exhibited only 2% apoptotic cells, representing about a 25-
fold increase at the highest concentration of Tan IIA as
comparedwiththecontrol(Figure 5(b)).Similarresultswere
obtained with the Apo-BrdU assay (Figure 5(c)).
3.5. Analysis of DNA Laddering. Detection of DNA laddering
on electrophoresis gels was used to conﬁrm the morpholog-
ical ﬁndings regarding the apoptotic action of Tan IIA. As
shown in Figure 6(a), Tan IIA-treated cells exhibited DNA
fragmentation at a concentration of 10μg/mL. Single-cell
gel electrophoresis revealed that the number of DNA strand
breaks was signiﬁcantly higher in cells of the Tan IIA-treated
groups compared with control (Figures 6(b) and 6(c)).
3.6. Role of the Caspase Signaling Pathway. The activation of
caspase proteases is well known in the induction process of
apoptosis. Using Western blot analysis, we conﬁrmed that
expression of caspase-3 and PARP proteins was altered at dif-
ferent concentrations of Tan IIA exposure, ranging from 2.5
to 10μg/mL. Tan IIA resulted in a dose-dependent increase
in the cleavage of caspase-3 and PARP (Figure 7(a)), which
triggered the apoptotic process. We treated cells with Ac-
DEVD-CHO,acaspase-3speciﬁcinhibitor,inthepresenceof
Tan IIA, to further conﬁrm whether or not caspase-3 played
a direct role in Tan IIA-induced apoptosis. The protein
expression of caspase-3 induced by Tan IIA, measured
by immunohistochemistry, was decreased (Figure 7(b)). At
the same time, we also used ﬂow cytometry to further
conﬁrm that Ac-DEVD-CHO attenuated Tan IIA-induced
apoptosis in keratinocytes (Figure 8). Apoptotic percentage
was decreased from 18.0% to 6.19% (P<0.05). Using an
ELISA method, we also determined the expression levels ofEvidence-Based Complementary and Alternative Medicine 7
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Figure 7:Analysisofapoptosis-relatedmodulatorsinducedbytanshinoneIIA.(a)Expressionofcleavedcaspase-3andPARPwasdetectedby
Westernblotting.(b)Keratinocyteswereexposedto10μg/mLtanshinoneIIAfor48hinthepresence(+)orabsence(−)of40μMA c-DEVD-
CHO (a speciﬁc caspase-3 inhibitor). Caspase-3 was detected by immunocytochemistry. (c) Cleaved caspase-3 activity was compared in
control versus tanshinone IIA-treated cells using the caspase-3 ﬂuorogenic substrate DEVD-afc. Scale bar = 50μm. Asterisk marks indicate
a signiﬁcant diﬀerence between control and tanshinone IIA-treated cells (∗P<0.05, ∗∗P<0.01).8 Evidence-Based Complementary and Alternative Medicine
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Figure 8: Eﬀects of Ac-DEVD-CHO on tanshinone IIA-induced apoptosis in keratinocytes. Apoptosis was determined by Apo-BrdU
staining. Ac-DEVD-CHO attenuated tanshinone IIA-induced apoptosis, indicating that tanshinone IIA causes apoptosis by a caspase-
dependent pathway. The asterisk indicates a signiﬁcant diﬀerence between control and tanshinone IIA-treated cells (∗P<0.05).
caspase-3 and caspase-8. The expression of caspase-3 was
increased at 12h and 24h (P<0.05; Figure 7(c)) while
there were no eﬀects on caspase-8 expression (P>0.05;
data not shown). These results suggest that the growth
inhibitory eﬀect of Tan IIA on keratinocytes occurs through
anapoptoticpathwayinducedbyoneofthecaspasecascades.
3.7. Tan IIA Induced Apoptosis of Keratinocytes without
Translocation of AIF. Apoptosis might proceed through the
activation of both caspase-dependent and -independent
pathways [16]. AIF, which is localized to the mitochondria
and released in response to death stimuli [17], was origi-
nally identiﬁed as a mitochondrial protein involved in cell
death through a caspase-independent pathway [18, 19]. We
examined whether or not AIF played a role in Tan IIA-
induced apoptotic cell death. AIF was analyzed by observing
its release from the mitochondria and translocation to the
nucleus by immunoﬂuorescence microscopy. As shown in
Figure 9(a), immunoﬂuorescence microscopy showed that
AIF did not translocate to the nucleus at exposures to several
concentrations of Tan IIA. Western blot analysis also showed
that there was no diﬀerence in AIF expression between
mitochondrial and cytosolic fractions (Figure 9(b)), which
is consistent with Tan IIA-induced apoptosis being at least
partially caspase dependent.
3.8. Tan IIA-Induced Mitochondrial Apoptotic Pathways.
To further explore the molecular mechanisms of Tan IIA
in apoptotic pathways in keratinocytes, we investigated
the inﬂuence of mitochondrial apoptosis signaling. Flow
cytometry and ﬂuorescence microscopy following JC-1
staining revealed a decrease of mitochondrial membrane
potential by Tan IIA. As shown in Figures 10(a) and 10(b),
the percentage of JC-1 green ﬂuorescence increased in the
Tan IIA-treated cells (due to loss of JC-1 aggregates in the
mitochondria) from 5.73% to 34.70%, indicating reducedEvidence-Based Complementary and Alternative Medicine 9
(a)
AIF DAPI Merge
5
10
T
a
n
I
I
A
(
µ
g
/
m
L
)
Control
GDPDH
Nucleus fraction
Cytoplasmic lysate
A
I
F
Fold
Fold
Fold
1 0.9 0.9 1.2
1 1 1.2 1
1 0.9 0.9 1.2
2.5 5 10
DMSO
Tan IIA (µg/mL)
(b)
Figure 9: Tanshinone IIA-induced apoptosis is mediated without AIF translocation. (a) Keratinocytes were treated with tanshinone IIA (5
and10μg/mL)for24h,incubatedwithantibodyagainstAIF,andAlexaFluor488-or594-conjugatedsecondaryantibodies(Invitrogen)were
used for immunoﬂuorescence staining. Nuclei were secondarily stained with DAPI. Purple nuclei due to overlap of AIF (red ﬂuorescence)
and nuclear staining (blue ﬂuorescence) means translocation of AIF was not observed. The scale bar in the ﬁrst panel represents 50μmf o r
both sections. (b) Western blot analysis showed no diﬀerence in AIF expression between the nucleus and cytoplasm.10 Evidence-Based Complementary and Alternative Medicine
12.7%
87%
33%
66.5%
25.5%
74.3%
DMSO
DMSO 5 10
6h 12h 24h
Tan IIA (µg/mL), 12h
Tan IIA (10µg/mL)
100
101
102
103
JC-1 orange dim
JC-1 orange bright
JC-1 orange dim
JC-1 orange bright
JC-1 orange dim
JC-1 orange bright
JC-1 orange dim
JC-1 orange bright
JC-1 orange dim
JC-1 orange bright
JC-1 orange dim
JC-1 orange bright
JC-1 orange dim
JC-1 orange bright
JC-1 orange dim
JC-1 orange bright
100
101
102
103
100
101
102
103
100
101
102
103
100
101
102
103
100
101
102
103
100
101
102
103
100
101
102
103
100 101 102 103 100 101 102 103 100 101 102 103 100 101 102 103
100 101 102 103 100 101 102 103 100 101 102 103 100 101 102 103
20
(a)
DMSO 5 10
F
l
u
o
r
e
s
c
e
n
c
e
i
n
t
e
n
s
i
t
y
(
%
)
Tan IIA (µg/mL), 12h
0
10
20
30
(b)
JC-1 aggregates JC-1 monomers Merge
DMSO
Tan IIA
(10µg/mL), 12h
14kD
37kD GAPDH
DMSO
Tan IIA (µg/mL), 24h
51 0
Fold
Fold
1 1.7 3.1
1 1.1 1.1 0
20
40
60
80
100
L
i
v
e
c
e
l
l
s
(
r
e
d
s
t
a
i
n
i
n
g
)
(
%
)
Tan IIA (µg/mL), 12h
DMSO 5 10
(d)
Cytochrome c
(c)
(e)
∗∗
∗∗
∗
∗
Figure 10: Tanshinone IIA-induced mitochondrial apoptotic pathways. (a) Mitochondrial membrane potential detection assay followed
by ﬂow cytometry determination. Tanshinone IIA decreased mitochondrial membrane potential occurred by concentration- and time-
dependent patterns. (b) Histograms represent means ± SD of JC-1 orange staining. (c) Cytochrome c was detected as a 14kD band. GAPDH
protein expression was used as the protein loading control. (d) Histogram of representative areas each from the control and treated groups.
(e) Mitochondrial red staining (JC-1 aggregates) are a sign of intact, live cells, which is more frequently found in the control group whereas
green cytosolic staining (JC-1 monomers) is present in all groups. To quantify the number of cells with intact mitochondrial membrane
potential, the number of cells with mitochondrial red staining was counted in 10 separate ﬁelds for each group and expressed as a percentage
of the total number of cells in the same ﬁeld. The scale bars represent 50μm. Asterisk marks indicate a signiﬁcant diﬀerence between control
and tanshinone IIA-treated cells (∗P<0.05, ∗∗P<0.01). The scale bar in the ﬁrst panel of (c) represents 50μm for both sections.Evidence-Based Complementary and Alternative Medicine 11
(a)
0 50 100 150
Channels (FL3 Lin-FL3 Lin)
0 50 100 150
Channels (FL3 Lin-FL3 Lin)
0 50 100 150
Channels (FL3 Lin-FL3 Lin)
0 50 100 150
Channels (FL3 Lin-FL3 Lin)
0
300
600
900
1200
0
200
400
600
800
N
u
m
b
e
r
Debris
Aggregates Dip S
Debris
Aggregates Dip S
Debris
Aggregates Dip S
Debris
Aggregates Dip S
DMSO
24 48 72
Tan IIA (10µg/mL)
N
u
m
b
e
r
0
200
400
600
800
N
u
m
b
e
r
0
200
400
600
N
u
m
b
e
r
0
20
40
60
80
C
e
l
l
c
y
c
l
e
d
i
s
t
r
i
b
u
t
i
o
n
(
%
)
S
DMSO 5
10 2.5
pCDK2 32kD
DMSO
Tan IIA (10µg/mL)
Tan IIA (µg/mL)
24h 48h 72h
56kD Tubulin
60kD Cyclin A
PCNA
DMSO 51 0
Tubulin
Fold
Fold
Fold
Fold
Fold
1
1 1.1
1.1
1
1
0.7
0.4
1
0.4 0.2
0.5 0.3
1
1 0.6 0.9
0.9
(b) (c)
32kD
56kD
Cell cycle 1
G1: 69.2%
S: 20.12%
G2M: 10.68%
Cell cycle 1
G1: 55.51%
S: 27.65%
G2M: 16.83%
Cell cycle 1
G1: 51.85%
S: 29.13%
G2M: 19.02%
Cell cycle 1
G1: 39.19%
S: 30.92%
G2M: 29.89%
Dip G1
Dip G2
Dip G1
Dip G2
Dip G1
Dip G2
Dip G1
Dip G2
G1 G2/M
∗
∗∗
∗∗
∗∗
∗
∗
∗
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mitochondrial membrane potential, and the number of
the cells with intact mitochondrial membrane potential
decreased in a Tan IIA concentration-dependent manner
(Figure 10(d)). Subsequently, cytochrome c content in the
cytoplasm was increased, as measured by Western blot
analysis (Figure 10(e)).
3.9. Analysis of Cell Cycle Alterations Induced by Tan IIA. The
inhibition of growth in Tan IIA-treated cells may result from
cell cycle eﬀects, cell death, or a combination of the two
processes. Thus, the cell cycle distribution of Tan IIA-treated
and control cells were determined by ﬂuorescence-activated
cell sorting analysis of Krishan-stained cells, which gives a
measure of DNA content, to explore another related
mechanism of growth inhibition for Tan IIA. As shown
in Figure 11(a), Tan IIA-treated cells exhibited a lower
proportion of cells in the G0-G1 phase (55.5%, 51.9%, and
39.2% for 24h, 48h, and 72h exposures to 10.0μg/mL
Tan IIA, resp.) as compared with control cells (69.2%). On
the other hand, a concomitant increase was observed in
the proportion of cells in the S/M phase (27.6%/16.8%,
29.1%/19.0%, and 30.9%/29.9% for 24h, 48h, and 72h
exposures to 10.0μg/mL Tan IIA, resp.) relative to that
observed in controls (20.1%/10.7%; Figures 11(a) and12 Evidence-Based Complementary and Alternative Medicine
11(b)). Western blot analysis was completed to com-
pare expression levels of various cell cycle-related proteins
between the control and Tan IIA-treated cells. Among them,
cyclin A and pCDK2, which are related to the S phase,
were decreased. Additionally, PCNA, which was originally
identiﬁed as an antigen that is expressed in the nuclei of cells
during the DNA synthesis phase of the cell cycle [20], and
is related to cell proliferation, was also decreased compared
with the control (Figure 11(c)).
4. Discussion
Tan IIA is a major phytochemical of a well-known Chinese
herbalmedicinecalledDanshenfromthedriedrootofSalvia
miltiorrhiza radix [21]. It has been widely used as a herbal
remedyintraditionalChinesemedicinetotreatpsoriasisand
other related skin diseases. According to the number and
quality of clinical trials with botanicals, the best evidence
exists for their use in the treatment of inﬂammatory skin
diseases, such as atopic dermatitis and psoriasis. However,
more controlled clinical studies are needed to determine the
eﬃcacy and risks of plant-derived products in dermatology
[22]. Although clinical results are encouraging, knowledge
about the pharmacological actions and clinical applications
are incomplete.
Psoriasis is one of the most unexplained and persistent
skin disorders. It is characterized by abnormal proliferation
and diﬀerentiation of keratinocytes, such that these cells
multiply up to ten-times faster than normal, typically on
the knees, elbows, and scalp. The common form, termed
“plaque psoriasis vulgaris,” is observed in more than 80% of
patients. In China, psoriasis aﬀects 0.123% of the population
and there have been more than 3 million cases reported since
1984 [23].
Althoughotherinvestigators[24]ha v emadetr emendous
progress, to our knowledge there have been no studies on
the antiproliferative eﬀect of Tan IIA in keratinocytes or
the underlying mechanism by which this chemical can be
used to treat psoriasis. The purpose of this study was to
provide evidence of the growth inhibitory eﬀects of Tan
IIA in keratinocytes. The MTS/PMS assay showed that Tan
IIA strongly inhibited the proliferation of keratinocytes. The
inhibition was both dose and time dependent (IC50 =
4.33μg/mL, 24h). Tan IIA also inhibited the colony growth
potential of cells in vitro.
Analysis of cell cycle status with Krishan staining showed
that Tan IIA induced cell cycle arrest at the S phase. Mor-
phological changes such as nuclear condensation were also
observed, DNA fragmentation was clearly demonstrated by
gel electrophoresis, and quantitative analyses by Hoechst/PI
staining and Apo-BrdU methods revealed that Tan IIA-
induced apoptosis occurred in a dose- and time-dependent
manner. Furthermore, appropriate changes in expression
of apoptosis-related proteins such as caspase-3, caspase-8,
and PARP were examined by Western blot analysis. Taken
together, these data suggest that Tan IIA acts by inducing
apoptosis of keratinocytes.
Mitochondrial outer membrane permeabilization (MO
MP) is often required for activation of the caspase proteases
thatcauseapoptoticcelldeath.Variousintermembranespace
(IMS) proteins, such as cytochrome c, promote caspase acti-
vation following their mitochondrial release [25]. Activated
caspase-3, a downstream cleavage product of the caspase
cascade, plays a central role in the execution of apoptotic cell
death. We assessed the eﬀects of Tan IIA on the activation
of caspase-3 in keratinocytes. ELISA data demonstrated the
dose-dependent ability of Tan IIA to increase caspase-3
activation. To further investigate the role of caspase-3 in
Tan IIA-induced apoptosis, keratinocytes were exposed to
10μg/mL Tan IIA for 48h in the presence or absence of
40μM Ac-DEVD-CHO, a speciﬁc caspase-3 inhibitor. Ac-
DEVD-CHO attenuated the induction of apoptosis by Tan
IIA, indicating that Tan IIA induces apoptosis by a caspase-
dependent mechanism.
AIF, initially characterized as a protein conﬁned within
the mitochondrial IMS of healthy cells, is a key protein
that can be released from mitochondria and translocated
to the nucleus during caspase-independent apoptosis [26].
Immunoﬂuorescence microscopy, however, showed that AIF
was not induced by Tan IIA and there was no translocation
from mitochondria. These results suggest that activation of
the caspase-independent apoptotic pathway mediated via
AIF translocation into the nucleus was not involved in Tan
IIA-induced apoptosis of keratinocytes.
Furthermore, our investigations found that the molec-
ular mechanism by which Tan IIA inhibits cell growth also
involves cell cycle arrest. To further deﬁne the function
of Tan IIA in cell cycle pathways, we investigated diﬀer-
ential expression proﬁles of various cell cycle regulatory
proteins using Western blot analysis and ﬂow cytometry
assays. Cyclin-dependent kinase 2 (CDK2), a member of a
highly conserved family of protein kinases that regulates the
eukaryotic cell cycle [27], interacts with retinoblastoma-like
p r o t e i n2 ,r e t i n o b l a s t o m a - l i k ep r o t e i n1 ,c y c l i nA 1[ 28, 29],
cyclin E1 [30], and p21 [29]. Recent research demonstrated
that Cdk2 has an unanticipated role in suppressing Myc-
induced senescence, suggesting that inhibition of Cdk2 may
have therapeutic eﬃcacy in the treatment of cancer [31].
Cyclin A binds to Cdk2 in the S phase and is required for
the cell to progress through the S phase. It has long been
believed that Cdk2 and its activator cyclin E play essential
roles in the progression of the mitotic cell cycle. However,
recent studies revealed that neither Cdk2 nor cyclin E is
essential in vivo. The expression and activity of the second
cyclin binding partner of Cdk2, cyclin A, as well as the
expression and degradation of the Cdk2 inhibitor p27Kip1
in the absence of Cdk2 [32], also appear to be important.
Cell cycle ﬂow cytometry analysis demonstrated that growth
of keratinocytes could be inhibited by treatment with Tan
IIA and this was due to time- and dose-dependent arrest in
Sa n dG 2/M phases. Cell cycle arrest was accompanied by
downregulation of pCdk2 and cyclin A proteins.
Taken together, our study provides novel insight into
the molecular mechanisms that underlie the signiﬁcant
antiproliferative eﬀects of Tan IIA in keratinocytes. TheEvidence-Based Complementary and Alternative Medicine 13
mechanism includes inducing S and G2/M phase arrest of
the cell cycle and triggering apoptosis through the caspase
signaling pathway. S and G2/M phase arrest may be mediated
bydownregulation ofpCDK2 andcyclinAproteins. TanIIA-
inducedapoptosisoccurredbymitochondrialdisruption,ac-
tivating caspase-3, but without aﬀecting AIF translocation.
The results partially elucidate the mechanism for therapeutic
eﬃcacy of Salvia miltiorrhiza radix in treatment of psoriasis.
Although the present work was conducted in normal
keratinocytes,animportantgoalforfuturestudiesistoassess
the eﬃcacy of Tan IIA in psoriatic keratinocytes. Such an
eﬃcacy would be based on ﬁnding a drug that was selectively
cytotoxic to psoriatic cells. Because such cells have a higher
rate of growth and proliferation than normal cells, it is
likely that they would be more sensitive to the cytotoxic
eﬀects of Tan IIA. Hence, one could presumably ﬁnd a
dose of Tan IIA that produced little eﬀect on growth and
proliferation of normal keratinocytes but was cytotoxic to
psoriatic keratinocytes.
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